Perianal Fistulizing Crohn’s Disease–Associated Anorectal and Fistula Cancers: Systematic Review and Expert Consensus
Serre-Yu Wong(Icahn School of Medicine at Mount Sinai), Jean–Frédéric Colombel(Icahn School of Medicine at Mount Sinai), Parakkal Deepak(Washington University in St. Louis), Celina Ang(Icahn School of Medicine at Mount Sinai), Amy L. Lightner(Cleveland Clinic), Phillip Lung(St. Mark's Hospital), David H. Ballard(Washington University in St. Louis), Antonino Spinelli(Istituti di Ricovero e Cura a Carattere Scientifico), Corina Behrenbruch(The Royal Melbourne Hospital), Bram Verstockt(Universitair Ziekenhuis Leuven), Ailsa Hart(St Mark's Hospital), Shaji Sebastian(University of Hull), David T. Rubin(University of California System), Michele Carvello(Humanitas University), Jeroen Geldof(Ghent University Hospital), Sergey Khaitov(Icahn School of Medicine at Mount Sinai), Anders Dige(Aarhus University), Emre Altınmakas(Icahn School of Medicine at Mount Sinai), Leon Shin‐han Winata(St Vincent's Hospital Melbourne), Cristiana Bonifacio(IRCCS Humanitas Research Hospital), Phil Tozer(St. Mark's Hospital), Elisabeth Giselbrecht(Icahn School of Medicine at Mount Sinai), L Hanna(St. Mark's Hospital), Dermot P.B. McGovern(Cedars-Sinai Medical Center), Carla Hamarth(University of Chicago), Lilli Lundby(Aarhus University Hospital), Benjamin L. Cohen(Cleveland Clinic), Elvira Diaz Brockmans(Universidad Iberoamericana), Benjamin D. McDonald(University of Chicago), Cathy Rowan(Beaumont Hospital), Stefan D. Holubar(Cleveland Clinic), Alexandros D. Polydorides(Icahn School of Medicine at Mount Sinai), David B. Sachar(Mount Sinai Hospital), Gabriele Bislenghi(KU Leuven), Cindy C Y Law(Massachusetts General Hospital)
Cited by 27
Related Papers
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
|Nature|2012|4.8k
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
|Gastroenterology|2021|2.6k
ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications
|Journal of Crohn s and Colitis|2018|1.8k
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
|The American Journal of Gastroenterology|2015|1.8k
ACG Clinical Guideline: Ulcerative Colitis in Adults
|The American Journal of Gastroenterology|2019|1.6k